Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Nature Communications|June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistanceSamuel J Wright, Izabella Zamora, Milan Parikh, et al.Nature Immunology|March 20, 2024
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapyJonathan H Chen, Linda T Nieman, Maxwell Spurrell, et al.Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.Biorxiv : the Preprint Server for Biology|April 17, 2023
Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy responseJonathan H Chen, Linda T Nieman, Maxwell Spurrell, et al.Cell Reports. Medicine|October 8, 2022
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.Biorxiv : the Preprint Server for Biology|November 11, 2020
Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsMichael R Filbin, Arnav Mehta, Alexis M Schneider, et al.Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.Cell Reports. Medicine|May 10, 2021
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactionsMichael R Filbin, Arnav Mehta, Alexis M Schneider, et al.Biorxiv : the Preprint Server for Biology|February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapyOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.Pageof 7